Which Option Fits Which Aim
These three options are non-surgical injections, each with a different mechanism and goal. The ChondroFiller injection delivers a CE-marked Class III collagen scaffold into the joint, aiming to support a worn surface and provide a matrix for the body's own cells to begin regenerating cartilage. Hyaluronic acid is a viscosupplementation injection that lubricates the joint for short-term symptom relief. Arthrosamid is a non-resorbable polyacrylamide hydrogel used specifically for mild-to-moderate knee osteoarthritis, intended to remain in the joint and cushion it over time. The right choice depends on the joint involved, the underlying diagnosis, and your treatment aim — not on brand name alone.
Who May Suit the ChondroFiller Injection
The ChondroFiller injection may suit people with osteoarthritis or localised joint wear — in the knee, hip, or other joints — who want a non-surgical, collagen-based option to help support the joint and ease symptoms. ChondroFiller is an acellular Type I collagen scaffold: cell-free, it gels in the joint within a few minutes of injection and is designed to recruit the body's own progenitor cells to the defect site. It is delivered as an ultrasound-guided outpatient injection and does not involve surgery, theatre, or general anaesthetic. It has biological potential, but it is not surgery and does not cure or reverse arthritis; the evidence is still developing and individual responses vary. A careful assessment decides suitability.
What to Expect from Knee Hyaluronic Acid
For knee osteoarthritis, hyaluronic acid is best understood as viscosupplementation: a symptom-control injection, not a repair or regenerative treatment. A 2022 systematic review covering 38 randomised trials and 5,025 patients found that hyaluronic acid generally offers modest benefit rather than a dramatic change. Side effects are usually local and short-lived, such as temporary pain or swelling at the injection site. It may be a reasonable option when the principal aim is short-term lubrication and pain relief rather than biological support.
Free non-medical discussion
Not sure what to do next?
Information only · No medical advice or diagnosis.
When Arthrosamid May Be Reasonable
Arthrosamid tends to enter the conversation for mild-to-moderate knee osteoarthritis when the aim is longer-lasting symptom control from a single injection. What sets it apart from hyaluronic acid is that it is a non-resorbable polyacrylamide hydrogel, intended to remain in the knee and integrate with the synovial lining rather than gradually break down. In the UK it has had more limited NHS availability and is typically discussed in the context of private care. It is specific to the knee; the evidence base for other joints is limited.
Arthrosamid vs ChondroFiller: Separating the Aims
The clearest way to distinguish them is by mechanism and intended goal. Arthrosamid is designed for knee osteoarthritis symptom control — a durable, non-resorbable cushioning hydrogel. The ChondroFiller injection is a collagen scaffold with a biological aim: to provide a structural matrix that supports host-cell cartilage regeneration, and it can be used across multiple joints, not only the knee.
A practical rule of thumb: for arthritic knee pain where the primary aim is longer-lasting symptom control, the more natural comparison is hyaluronic acid versus Arthrosamid. When a collagen-based, biologically active scaffold is the clinical aim — and the diagnosis calls for it — the ChondroFiller injection may be considered, and it is available across a wider range of joints. Neither should be thought of as equivalent, and neither replaces a proper diagnostic work-up.
Access and the Next Step
In UK practice, availability and realistic suitability often shape the shortlist as much as preference does. What ultimately decides the right option is the clinical work-up — the specific diagnosis, the joint involved, the severity and pattern of osteoarthritis, and the imaging findings — not the brand name. At the London Cartilage Clinic, Professor Paul Lee can assess which approach, if any, is appropriate for your situation, with realistic expectations about what each injection can and cannot achieve.
References
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- It is a non-surgical, outpatient injection of a CE-marked Class III collagen scaffold used to support joint preservation in osteoarthritis and localised joint wear. The scaffold provides a matrix for the body's own cells to begin regenerating cartilage. It is not surgery and not a cure; the evidence is still developing and benefits vary between individuals.
- People with very advanced, widespread arthritis or significant other joint changes may be better served by alternative approaches. A careful clinical assessment — including the diagnosis, joint involved, and imaging — is needed to determine suitability.
- It lubricates the joint for short-term symptom relief (viscosupplementation). Clinical evidence suggests generally modest benefit. It does not change the underlying joint structure or act as a regenerative scaffold.
- For mild-to-moderate knee osteoarthritis when the aim is longer-lasting symptom control from a single, non-resorbable hydrogel injection. It is knee-specific; evidence for other joints is limited.
- By the diagnosis, the joint involved, the severity and pattern of osteoarthritis, and imaging findings — not by brand alone. A specialist assessment can clarify which option, if any, suits your specific situation and set realistic expectations.
London Cartilage Clinic
Ready to explore your options?
Our consultant-led team specialises in cartilage repair, regeneration and replacement — tailored to your diagnosis and long-term goals.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
